360 High-Risk Vulnerability Immunization Tool V2.0 vs Proton Pass: Side-by-Side Comparison (2026)
Features, pricing, ratings, and pros and cons, compared head to head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). Proton Pass is a free password management tool. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack. Independent and vendor-neutral: our scores and rankings are earned, never bought — sponsored placement is always labeled.
CST VerdictShort answer
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats. Teams managing passwords across distributed or privacy-conscious workforces will find Proton Pass valuable for its zero-knowledge architecture; your credential data stays encrypted end-to-end even from Proton itself, which matters in regulated industries where data residency audits are common. The free tier removes procurement friction for pilots, and the integration with Proton Mail and VPN creates a self-contained ecosystem if you're already in that stack. Skip this if you need tight enterprise directory sync, advanced threat intelligence on breached credentials, or the kind of audit logging that Fortune 500 procurement demands.
Based on our analysis of core features, integrations, company size fit, deployment model, here is our conclusion:
